Drug Delivery Systems Market Size

Drug Delivery Systems Market size was over USD 47.47 billion in 2024 and is expected to exceed USD 122.69 billion by the end of 2037, growing at over 8.1% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of drug delivery systems is evaluated at USD 50.58 billion.

The growth of this market can be attributed to the increased availability of vaccines for different types of diseases such as typhoid, tuberculosis, influenza, hepatitis, and others. According to a report, in 2021 the global coverage of hepatitis B is around 80% for Haemophilus influenza type B vaccine nearly 71% and nearly 80% of infants all over the world received polio vaccination.

The cases of chronic disease are constantly rising owing to lifestyle disorders, unhealthy eating habits, and sleeping disorders. According to the World Health Organization, about 17.9 million people die of cardiovascular disease every year, and cardiovascular is the primary reason for most of the deaths in the world.

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of drug delivery systems is evaluated at USD 50.58 billion.

The drug delivery systems market size was over USD 47.47 billion in 2024 and is expected to exceed USD 122.69 billion by the end of 2037, growing at over 8.1% CAGR during the forecast period i.e., between 2025-2037. The growing digital drug delivery and increasing prevalence of chronic diseases will propel the market growth.

Europe industry is anticipated to maintain a sizable revenue share by 2037, owing to growing recognition of cutting-edge medication delivery methods and acceptance of cutting-edge technology in the region.

The major players in the market include BD (Becton, Dickinson, and Company), Gerreshelmer AG, Baxter, Nemara, Kindeva Drug Delivery, West Pharmaceutical Services Inc., Ypsomed, Medtronic Inc., E3D Elcam Drug Delivery Devices, Astra Zeneca, Merck KGaA.

Drug Delivery Systems Market Size